Humana

HUM

Market cap $33B

HUM teams up with Atlas Oncology to make a cancer care model available for its eligible MA members in TN and MS starting in 2026.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana expands cancer care for eligible Medicare Advantage members in Tennessee and Mississippi through Atlas Oncology partnership.

LOUISVILLE, Ky.--(BUSINESS WIRE)--CenterWell Pharmacy to dispense obesity management medications as part of new, employer-focused program.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 4Q25 earnings call may be accessed via Humana's Investor Relations page.

HUM sits at a crossroads as Medicare Advantage pressures cap near-term upside, but resilience versus peers argues for patience, not panic.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The U.S. Defense Department on Wednesday said it was exercising an option to award Humana a $7.3 billion deal for health care and administrative support services.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana, Nurses on Boards Coalition announce new partnership to mentor emerging nurses.

LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new report, “Strengthening Belonging for Underserved Boys.” The report explores how loneliness has become a pressing public health issue among boys, particularly those from racially and ethnically diverse backgrounds, rural communities, LGBTQ+ identities, and boys with differing physical and mental abilities. According to a Gallup poll, 25%.

SAN DIEGO, Dec. 16, 2025 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces an update in the lawsuit that is currently pending for certain investors in NYSE: HUM shares. Investors who purchased shares of Humana Inc. prior to July 2022 and continue to hold any of those NYSE: HUM shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.